Article
Topiramate and psychiatric adverse events in patients with epilepsy.
Epilepsia - 1 May 2003
Mula Marco, Trimble Michael R, Lhatoo Samden D, Sander Josemir W A S
Abstract excerpt
PURPOSE: The aim of this study was to determine the prevalence of psychiatric adverse events (PAEs) in patients with epilepsy treated with topiramate (TPM). Classification, relation to TPM dosing, and outcome were evaluated to identify a patient profile at risk of developing PAEs. METHODS: We evaluated the data of the first consecutive and prospectively collected patients in therapy with TPM. RESULTS: Follow-up...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
